Skip to content
Open access

TSH RECEPTOR RESISTANCE PRESENTING AS REFRACTORY CONGENITAL HYPOTHYROIDISM: VARIABLE EXPRESSIVITY ACROSS THREE GENERATIONS

Oct 2026 · Thyroid Research and Practice · 0 citations

Abstract

Loss-of-function mutations in the TSH receptor (TSHR) gene are a rare cause of congenital hypothyroidism with thyroid hypoplasia. Homozygous mutations cause severe neonatal hypothyroidism, while heterozygous carriers manifest subclinical hypothyroidism. We report a family with suspected TSHR mutation showing variable expressivity across three generations. A 7-year-old boy, born of second-degree consanguineous parentage, was diagnosed with congenital hypothyroidism on day 3 of life (TSH >150 μIU/mL, low free T4) during evaluation for neonatal respiratory distress and prolonged jaundice. Despite levothyroxine therapy, TSH remained persistently elevated. At presentation, TSH was 44.7 μIU/mL on levothyroxine 75 μg (3.2 μg/kg/day) with confirmed compliance. Free T4 was elevated at 1.9 ng/dL (reference: 0.7–1.3), demonstrating adequate hormone levels despite raised TSH. Anti-TPO and anti-Tg were negative. Height was above the 75th centile with no goitre. Bone age was delayed at 5 years. Ultrasonography revealed a hypoplastic thyroid gland. Tc-99m pertechnetate scan showed absent thyroid uptake with preserved salivary gland uptake, suggesting TSH unresponsiveness at the receptor level. Family screening revealed milder phenotypes. The elder sister (on levothyroxine 1.8 μg/kg, diagnosed at age 3) had TSH 5.16 with free T4 1.59 ng/dL. The mother (on levothyroxine 75 μg, diagnosed at age 20) had TSH 7.5 with free T4 3.7 ng/dL. The untreated father had TSH 8.8 μIU/mL. The severe phenotype in the consanguineous index case with milder forms in relatives is consistent with homozygous TSHR loss-of-function in the proband and heterozygous carrier status in family members. Genetic sequencing is awaited. This case illustrates that persistently elevated TSH with adequate free hormone levels, absent thyroid tracer uptake, and a hypoplastic gland should prompt consideration of TSHR mutations. Family screening and genetic testing are essential for accurate diagnosis and appropriate management.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.